Vaginal Atrophy Clinical Trials

A listing of Vaginal Atrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 260 clinical trials
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer

A Phase 1/2, open label, multi-center study to evaluate the safety, efficacy and tolerability of KY1044 as single agent and in combination with anti-PD-L1 (atezolizumab) in adult patients with selected advanced malignancies, who are ineligible for or there are no available therapies known to confer a clinical benefit for their …

measurable disease
breast cancer
squamous cell carcinoma of head and neck
squamous cell carcinoma
carcinoma
  • 101 views
  • 09 Jun, 2022
  • 10 locations
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors

A multicenter open-label phase 1/1b study to evaluate the safety and preliminary efficacy of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors

serum pregnancy test
neuropathy
chemotherapy regimen
solid tumors
solid tumour
  • 43 views
  • 30 Apr, 2022
  • 7 locations
Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

the same for all groups. Thus, a direct comparison between conventional treatment (topical hormones), laser treatment of the vaginal atrophy and normal condition without treatment will be made. The

smear
cancer
estriol
Accepts healthy volunteers
  • 0 views
  • 09 May, 2022
  • 1 location
Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy (SIVAM)

Vulvovaginal atrophy is common after menopause, with a significant negative effect on quality of life. Large cohort studies have reported the prevalence of vaginal dryness to be between 27% and 55% and dyspareunia between 32% and 41%. Management of urogenital atrophy includes lifestyle modification, nonhormonal treatments (vaginal lubricants or moisturizers, …

stress urinary incontinence
  • 0 views
  • 14 Jun, 2022
  • 1 location
Polynucleotides Efficacy in the Genitourinary Syndrome of Menopause

The aim of this study is to determine the efficiency of local polynucleotides-based therapy in the treatment of the genitourinary syndrome of menopause, in postmenopausal Mexican women, and to compare it with gold standard therapy with local conjugated estrogens.

genitourinary syndrome of menopause
conjugated estrogens
estrogen
  • 0 views
  • 25 Jul, 2022
  • 1 location
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

The purpose of this research is to gather information on the safety and effectiveness of Intrarosa®, also known as Dehydroepiandrosterone (DHEA), and prasterone. By doing this study, the investigators hope to learn if Intrarosa® can improve vaginal discomfort. Participants will be assigned to one of two groups. One group will …

  • 0 views
  • 14 Jun, 2022
  • 1 location
Vulvovaginal Atrophy Correction Using Neodymium Laser

direct comparison between conventional treatment (topical hormones), laser treatment and combine laser and topical hormones therapy of the vaginal atrophy will be made. The main hypothesis of the study

smear
estriol
hormone therapy
  • 0 views
  • 21 Jul, 2022
  • 1 location
Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo (PIVoT)

associated with menopause. After menopause, there is a chemical changes in the vagina that may predispose to bacterial infections. The role of vaginal estrogen creams to restore vaginal atrophy and

Accepts healthy volunteers
  • 0 views
  • 03 May, 2022
  • 1 location
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

, inflammation and a breakdown of natural barriers that keep the vagina healthy and protected from infections. Some menopausal women develop a condition called vaginal atrophy, which causes vaginal dryness

vaginal atrophy
serum estradiol
antiretroviral
follicle stimulating hormone
Accepts healthy volunteers
  • 0 views
  • 19 Dec, 2021
  • 1 location
Clinical Trial of "Magic Gyno" Laser Device

The aim of this prospective study is investigation of efficiency and safety of medical device "Magic Gyno" in accordance with the stated purpose. To assess the condition of the vaginal walls and vulva before and after laser treatment, the following methods will be used: gynecology examination, vaginal health index, clinical …

mixed incontinence
smear
stress urinary incontinence
body mass index
prolapse
  • 0 views
  • 10 Aug, 2022
  • 1 location